Dagan, Ron <br/><br/>
Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components.  [electronic resource] 

 -  Infection and immunity  Sep 2004 
 - 5383-91 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0019-9567 
<br/><br/><label>Standard No.: </label>10.1128/IAI.72.9.5383-5391.2004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Bacterial--blood<br/>Diphtheria Toxoid--administration & dosage<br/>Diphtheria-Tetanus-acellular Pertussis Vaccines--administration & dosage<br/>Humans<br/>Immunization<br/>Immunization, Secondary<br/>Infant<br/>Pertussis Vaccine--administration & dosage<br/>Pneumococcal Vaccines--administration & dosage<br/>Poliovirus Vaccine, Inactivated--administration & dosage<br/>Polysaccharides--administration & dosage<br/>Tetanus Toxoid--administration & dosage<br/>Vaccines, Combined--administration & dosage<br/>Vaccines, Conjugate--administration & dosage